<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7534958\results\search\zoonosis\results.xml">
  <result pre="under the terms of the Creative Commons Attribution License Abstract" exact="Coronavirus disease 2019" post="(COVID-19) caused by the severe acute respiratory syndrome coronavirus"/>
  <result pre="drug discovery replication cycle drug targets fig-count: table-count: ref-count: Epidemiology" exact="Coronavirus disease 2019" post="(COVID-19) caused by the severe acute respiratory syndrome coronavirus"/>
  <result pre="in alpha coronavirus (229E, NL63) or beta coronavirus [OC43, HKU1," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV) and"/>
  <result pre="mechanism of infection - At present, the mechanisms that underlie" exact="SARS-CoV-2 infection" post="have not been directly described. Nonetheless, they seem to"/>
  <result pre="for drug repurposing candidates and compounds 1-14 under investigation against" exact="coronavirus disease 2019" post="(COVID-19). Nsp3 is the largest protein encoded by CoVs"/>
  <result pre="for drug repurposing candidates and compounds 15-29 under investigation against" exact="coronavirus disease 2019" post="(COVID-19). Spike protein (S) is a viral type I"/>
  <result pre="occurs in MERS-CoV.60 It is still unclear its role in" exact="SARS-CoV-2 infection," post="but it is speculated that the ubiquitous expression of"/>
  <result pre="the cell. Theoretically, this role may also be played in" exact="SARS-CoV-2 infection," post="as predicted by computational analysis.154 Recently, there has been"/>
  <result pre="conformations. TABLE I In silico studies of drug repurposing for" exact="coronavirus disease 2019" post="(COVID-19) Repurposed drug Previous use Predicted targets Discovery origin"/>
  <result pre="for drug repurposing candidates and compounds 30-49 under investigation against" exact="coronavirus disease 2019" post="(COVID-19). Ge and coworkers constructed a virus-related knowledge graph"/>
  <result pre="approaches), cellular in vitro and in vivo animal models of" exact="SARS-CoV-2 infection," post="are pivotal for the discovery of molecular pathways involved"/>
  <result pre="In vitro and in vivo studies of drug repurposing for" exact="coronavirus disease 2019" post="(COVID-19) Repurposed drug Previous use Targets In vitro potency"/>
  <result pre="Targets In vitro potency (EC50) Selectivity index Reference Remdesivir (8)" exact="Ebola" post="RNA polymerase 0.77 Î¼M 129.9 194 Chloroquine (20) /"/>
  <result pre="HCQ (26) is also being studied in vitro as a" exact="SARS-CoV-2 infection" post="inhibitor acting on both virus entry, as well as"/>
  <result pre="of the two compounds against an in vitro model of" exact="SARS-CoV-2 infection" post="on Vero E6 cells, demonstrated that CQ (20) is"/>
  <result pre="was more potent than CQ (20) to inhibit in vitro" exact="SARS-CoV-2 infection" post="(EC50 0.72 vs 5.47 Î¼M).196 The authors also performed"/>
  <result pre="discovery pipeline comprising in vitro, and in vivo models of" exact="SARS-CoV-2 infection" post="is particularly important to identify new antivirals for human"/>
  <result pre="Cohen, which summarised several clinical studies on drug repurposing for" exact="Covid-19" post="reported so far.44 It is worth noting that many"/>
  <result pre="by day. TABLE III Clinical studies of drug repurposing for" exact="coronavirus disease 2019" post="(COVID-19) Repurposed drug Study characteristics Estimated enrolment Dosage Characteristics"/>
  <result pre="lopinavir (1)-ritonavir (2) treatment compared to standard care in severe" exact="Covid-19" post="patients 220 Ritonavir (2)/lopinavir (1) plus interferon Phase II,"/>
  <result pre="This prodrug was already investigated in clinical trial testing for" exact="Ebola" post="virus with no effect but showed efficiency against different"/>
  <result pre="testing in SARS-CoV-2.235 A total of 199 patients confirmed severe" exact="SARS-CoV-2 infection" post="were randomly designated to be given either (1)/(2) (400"/>
  <result pre="a drug that could be used in the treatment of" exact="COVID 19" post="patients, since its anti-inflammatory activity could minimise inflammatory complications"/>
  <result pre="patients, since its anti-inflammatory activity could minimise inflammatory complications in" exact="COVID 19" post="patients. According to the platform ClinicalTrials.gov, there are 14"/>
  <result pre="most cost-effective of the three of them. In conclusion -" exact="SARS-CoV-2 infection" post="is a life-threatening disease with such a high transmission"/>
  <result pre="approved or investigational drugs that can be repurposed to treat" exact="SARS-CoV-2 infection." post="As reviewed here, over 10 targets distributed amongst distinct"/>
  <result pre="COVID-19Anaesthesia202075797697732339251 33DengYLiuWLiuKFang Y-YShangJZhouLClinical characteristics of fatal and recovered cases of" exact="coronavirus disease 2019" post="in Wuhan, China a retrospective studyChin Med J (Engl)2020133111261126732209890"/>
  <result pre="blocked by a clinically proven protease inhibitorCell20201812 66SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for" exact="Coronavirus disease 2019" post="(COVID-19)JAMA2020323181824183632282022 67BoopathiSPomaABKolandaivelP.Novel 2019 coronavirus structure, mechanism of action, antiviral"/>
  <result pre="- shared pathways with therapeutic implicationsEndocr Rev2020413457470 152StrolloRPozzilliPDPP4 inhibition: preventing" exact="SARS-CoV-2 infection" post="and/or progression of COVID-19?Diabetes Metab Res Rev202010.1002/dmrr.3330 153IacobellisGCOVID-19 and"/>
  <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov202061161632194981 207McChesneyEWAnimal toxicity and pharmacokinetics of hydroxychloroquine"/>
  <result pre="double-blind, placebo-controlled, multicentre trialLancet2020395102361569157832423584 216BeigelJHTomashekKMDoddLEMehtaAKZingmanBSKalilACet al.Remdesivir for the treatment of" exact="Covid-19" post="- Preliminary reportN Engl J Med202010.1056/NEJMoa2007764 217GaoJTianZYangXBreakthrough chloroquine phosphate"/>
 </snippets>
</snippetsTree>
